These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8631046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Disopyramide improves the balance between myocardial oxygen supply and demand in patients with hypertrophic obstructive cardiomyopathy.
    Niki K, Sugawara M, Asano R, Oka T, Kondoh Y, Tanino S, Iwade K, Magosaki N, Kasanuki H, Hosoda S.
    Heart Vessels; 1997; 12(3):111-8. PubMed ID: 9496461
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE.
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J.
    J Cardiol; 1991 Feb; 21(1):75-86. PubMed ID: 1817183
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ.
    J Am Coll Cardiol; 2005 Apr 19; 45(8):1251-8. PubMed ID: 15837258
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
    Minami Y, Kajimoto K, Kawana M, Hagiwara N, Sherrid MV.
    Int J Cardiol; 2010 May 28; 141(2):195-7. PubMed ID: 19097655
    [Abstract] [Full Text] [Related]

  • 17. Effect of propranolol and disopyramide on left ventricular function at rest and during exercise in hypertrophic cardiomyopathy.
    Hartmann A, Kühn J, Hopf R, Klepzig H, Standke R, Kober G, Maul FD, Hör G, Kaltenbach M.
    Cardiology; 1992 May 28; 80(2):81-8. PubMed ID: 1611637
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
    Terrosu P, Franceschino V, Contini GM, Dore L, Ibba GV.
    G Ital Cardiol; 1984 Jan 28; 14(1):63-6. PubMed ID: 6538527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.